Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age

BJU International

Volumn 95, Issue 1, 2005, Pages 110-116

  Giuliano, François ^a   Donatucci, Craig ^b   Montorsi, Francesco ^c   Auerbach, Stephen ^d   Karlin, Gary ^e   Norenberg, Christiane ^f   Homering, Martin ^f   Segerson, Thomas ^g   Eardley, Ian ^h  

^a BICÊTRE HOSPITAL   (France)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d California Professional Research   (United States)

^e Lawrenceville School   (United States)

^f BAYER PHARMA AG   (Germany)

^g Bayer Inc   (Canada)

^h ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Elderly; Erectile dysfunction; Oral PDE 5 inhibitors; Placebo controlled clinical trial

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; VARDENAFIL;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ERECTILE DYSFUNCTION; FLUSHING; GLOBAL ASSESSMENT QUESTION; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PENIS ERECTION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RHINITIS; SEXUAL INTERCOURSE; SIDE EFFECT; TINNITUS; DRUG RESPONSE; MALE SEXUAL DYSFUNCTION; SEXUAL FUNCTION;

ADULT; AGED; DOUBLE-BLIND METHOD; HUMANS; IMIDAZOLES; IMPOTENCE; MALE; MIDDLE AGED; MULTICENTER STUDIES; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SULFONES; TREATMENT OUTCOME; TRIAZINES;

EID: 12544256530     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.05260.x     Document Type: Article

References (38)

1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83-90
2. Giuliano F, Chevret-Measson M, Tsatsaris A, Reitz C, Murino M, Thonneau P. Prevalence of erectile dysfunction in France: results of an epidemiological survey of a representative sample of 1004 men. Eur Urol 2002; 42: 382-9
3. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61
4. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537-44
5. Monga M, Bettencourt R, Barrett-Connor E. Community-based study of erectile dysfunction and sildenafil use: the Rancho Bernardo study. Urology 2002; 59: 753-7
6. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res 2000; 12: 305-11
7. Blanker MH, Bosch JL, Groeneveld FP et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50-78 years old: prevalence, concern, and relation to sexual activity. Urology 2001; 57: 763-8
8. Bortz WM 2nd, Wallace DH, Wiley D. Sexual function in 1,202 aging males: differentiating aspects. J Gerontol A Biol Sci Med Sci 1999; 54: M237-41
9. Blanker MH, Bohnen AM, Groeneveld FP et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc 2001; 49: 436-42
10. Hellstrom W, Gittelman M, Karlin G et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 2002; 23: 763-71
11. Brock G, Nehra A, Lipshultz LI et al. Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 2003; 170: 1278-83
12. Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T. Vardenafil, a new phosphodiesterase type 5 Inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 2003; 26: 777-83
13. Steidle C, Feldman R, Lettieri J, Agarwal V, Segerson T. Pharmacokinetics of vardenafil (a new selective PDE5 inhibitor) in the elderly and subgroup data on efficacy and safety in elderly patients with erectile dysfunction. J Am Geriatr Soc 2001; 49: S103
14. Porst H, Young JM, Schmidt AC, Buvat J. Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups. Urology 2003; 62: 519-24
15. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30
16. Goldfischer E, Eardley I, Segerson T, the Vardenafil EU, NA. Study Groups. Vardenafil improves erectile function in men with significant comorbidities associated with erectile dysfunction. J Urol 2002; 167 (Suppl. 4): 178, A714
17. Donatucci C, I. E, Thibonnier M, and the Vardenafil EU and NA Study Groups. Vardenafil improves erectile function of etiology or baseline severity in men with erectile dysfunction. J Urol 2002; 167 (Suppl. 4): 178, A715
18. Brock G, Porst H, Stief C, Beneke M, Ulbrich E, Saenz de Tejada I. Influence of prior sildenafil use on the efficacy of vardenafil in men with erectile dysfunction: retrospective analysis of a two year study. J Urol 2004; 171: 240, A906
19. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40-69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol 2000; 163: 460-3
20. Seidman SN. The aging male, androgens, erectile dysfunction, and depression. J Clin Psychiatry 2003; 64 (Suppl. 10): 31-7
21. Lunenfeld B. Replacement therapy in the aging male. J Endocrinol Invest 2002; 25: 2-9
22. Dahiya R, Chui R, Perinchery G, Nakajima K, Oh BR, Lue TF. Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction. Int J Impot Res 1999; 11: 201-6
23. Nehra A, Gettman MT, Nugent M et al. Transforming growth factor-beta 1 (TGF-beta1) is sufficient to induce fibrosis of rabbit corpus cavernosum in vivo. J Urol 1999; 162: 910-5
24. Behr-Roussel D, Bernabe J, Compagnie S et al. Distinct mechanisms implicated in atherosclerosis-induced erectile dysfunction in rabbits. Atherosclerosis 2002; 162: 355-62
25. Ferrini M, Magee TR, Vernet D, Rajfer J, Gonzalez-Cadavid NF. Aging-related expression of inducible nitric oxide synthase and markers of tissue damage in the rat penis. Biol Reprod 2001; 64: 974-82
26. Haas CA, Seftel AD, Razmjouei K, Ganz MB, Hampel N, Ferguson K. Erectile dysfunction in aging: upregulation of endothelial nitric oxide synthase. Urology 1998; 51: 516-22
27. Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJ. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl 2003; 24: S17-37
28. Lyons D, Roy S, Patel M, Benjamin N, Swift CG. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin Sci (Lond) 1997; 93: 519-25
29. Goldstein I. The association of ED (erectile dysfunction) with ED (endothelial dysfunction) in the International Journal of Impotence Research: The Journal of Sexual Medicine. Int J Impot Res 2003; 15: 229-30
30. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 2003; 91: 3A-6A
31. Angulo J, Cuevas P, Fernandez A et al. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun 2003; 312: 1202-8
32. Maas R, Schwedhelm E, Albsmeier J, Boger RH. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med 2002; 7: 213-25
33. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003; 89: 251-3
34. Glover BH. Problems of aging: sex in the aging. Postgrad Med 1975; 57: 165-9
35. Gott M, Hinchliff S. How important is sex in later life? The views of older people. Soc Sci Med 2003; 56: 1617-28
36. Beutel ME, Schumacher J, Weidner W, Brahler E. Sexual activity, sexual and partnership satisfaction in ageing men - results from a German representative community study. Andrologia 2002; 34: 22-8
37. Wysowski DK, Swann J. Use of medications for erectile dysfunction in the United States, 1996 through 2001. J Urol 2003; 169: 1040-2
38. Steidle C, Porst H, Hollister A, Segerson T. Vardenafil demonstrated similar efficacy and tolerability among older and younger patients with marginal differences PK characteristics between age groups. Int J Impot Res 2001; 13 (Suppl. 5): S63